Could this be the next big breakthrough for hair loss?
NCT ID NCT07317544
Summary
This early-stage clinical trial is testing a new medication called ABS-201 to see if it is safe and well-tolerated for improving hair growth. The study will involve healthy adults and people with common genetic hair loss (pattern baldness). Participants will receive either the actual drug or a placebo and will be monitored for about a year to check for side effects and see how the drug behaves in the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ANDROGENETIC ALOPECIA (AGA) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Nucleus Network
RECRUITINGMelbourne, Victoria, 3004, Australia
Contact
-
Sinclair Dermatology
NOT_YET_RECRUITINGMelbourne, Victoria, 3002, Australia
Contact
Conditions
Explore the condition pages connected to this study.